الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
61 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Doaa Mohamed Fouad Mahmoud 2021
62 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
63 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Matta Gerges Mounir Meshreky 2021
64 Validation of imaging reporting and data system of coronavirus disease 2019 lexicons CO-RADS and COVID-RADS with radiologists’ preference: a multicentric study Dr. Adel Gomaa Mohamed Gabr 2021
65 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Dr. Mayada Fawzy Sedik Farghaly 2021
66 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Dr. Hanaan Ahmed Mohammed Ahmed 2021
67 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Mohammed Morsy Hassan 2021
68 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		Dr. Mayada Fawzy Sedik Farghaly 2020
69 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Dr. Amen Hamdy Zaki Ali 2020
70 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Yasmine Ali Roshdy 2020